Skip to main content
MADRIGAL PHARMACEUTICALS, INC. logo

MADRIGAL PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · MDGL ISIN · US5588681057 LEI · 549300CHIMT2EUSNJB60 US Manufacturing
Filings indexed 1,022 across all filing types
Latest filing 2024-08-07 Interim / Quarterly Rep…
Country US United States of America
Listing US MDGL

About MADRIGAL PHARMACEUTICALS, INC.

https://www.madrigalpharma.com/

Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious and progressive liver disease with high unmet medical need. The company's research led to the first U.S. Food and Drug Administration (FDA)-approved treatment for MASH. Madrigal's therapeutic goal is to halt or reverse liver scarring (fibrosis) and resolve the disease before patients experience severe complications, including cirrhosis, liver failure, and the need for transplantation.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2024
2024-08-07 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 7, 2024, by Madrigal Pharmaceuticals, Inc. It announces the issuance of a press release regarding the company's financial results for the fiscal quarter ended June 30, 2024. The document explicitly states that the press release is being furnished as an exhibit and incorporated by reference, and the Form 8-K itself does not contain detailed financial statements or substantive financial data. The document length is 3722 characters, which is relatively short and consistent with an announcement rather than a full financial report. According to the rules, such a document that announces or furnishes a press release of quarterly financial results without containing the full report itself should be classified as an Earnings Release (ER).
2024-08-07 English
4
Director's Dealing
2024-06-28 English
4
Director's Dealing
2024-06-28 English
4
Director's Dealing
2024-06-28 English
4
Director's Dealing
2024-06-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.